世界の抗炎症治療市場2020-2024

◆英語タイトル:Global Anti-Inflammatory Therapeutics Market 2020-2024
◆商品コード:IRTNTR41324
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年3月24日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、ヨーロッパ、北米、その他の地域
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは抗炎症治療の世界市場について調査・分析し、エグゼクティブサマリー、市場環境、市場規模、ファイブフォース分析、顧客状況、地域別状況、市場の要因と課題、企業状況、企業分析などを含め、次の構成でお届けいたします。
・エグゼクティブサマリ
・市場環境
・市場規模
・ファイブフォース分析
・顧客状況
・地域別状況
・市場の要因・課題
・企業状況
・企業分析
【レポートの概要】

Global Anti-Inflammatory Therapeutics Market 2020-2024
Technavio has been monitoring the global anti-inflammatory therapeutics market 2020-2024 and it is poised to grow by USD 27.53 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. Our reports on global anti-inflammatory therapeutics market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of imid. In addition, emergence of novel anti-inflammatory drugs is anticipated to boost the growth of the global anti-inflammatory therapeutics market as well.

Market Segmentation
Technavio’s global anti-inflammatory therapeutics market 2020-2024 is segmented as below:
Application:
• RA
• Psoriasis
• MS

Geographic Segmentation:
• Asia
• Europe
• North America
• ROW

Key Trends for global anti-inflammatory therapeutics market 2020-2024 growth
This study identifies emergence of novel anti-inflammatory drugs as the prime reasons driving the global anti-inflammatory therapeutics market 2020-2024 growth during the next few years.

Prominent vendors in global anti-inflammatory therapeutics market 2020-2024
We provide a detailed analysis of around 25 vendors operating in the global anti-inflammatory therapeutics market 2020-2024, including some of the vendors such as AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/anti-inflammatory-therapeutics-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

•Executive Summary
o Market Overview
•Market Landscape
o Market ecosystem
o Value chain analysis
•Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
•Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
•Customer landscape
o Overview
•Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher-priced units
o Market challenges
o Market trends
•Vendor Landscape
o Overview
o Landscape disruption
•Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AbbVie Inc.
o Amgen Inc.
o AstraZeneca Plc
o Bayer AG
o F. Hoffmann-La Roche Ltd.
o GlaxoSmithKline Plc
o Johnson & Johnson
o Merck & Co., Inc.
o Novartis AG
o Pfizer Inc.
•Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
•1.Key Finding 1
•2.Key Finding 2
•3. Key Finding 3
•4. Key Finding 5
•5. Key Finding 6
•6. Key Finding 7
•7. Key Finding 8
•8. Key Finding 9
•9. Market in focus
•10. Parent market
•11. Market characteristics
•12. Product / Service portfolio of key vendors included in the market definition
•13. Market segments
•14. Global – Market size and forecast 2019 – 2024 ($ billion)
•15. Global market: Year-over-year growth 2019 – 2024 (%)
•16. Five forces analysis 2019 & 2024
•17. Bargaining power of buyers
•18. Bargaining power of suppliers
•19. Threat of new entrants
•20. Threat of substitutes
•21. Threat of rivalry
•22. Market condition – Five forces 2019
•23. RA – Market size and forecast 2019-2024 ($ billion)
•24. RA – Year-over-year growth 2019-2024 (%)
•25. Psoriasis – Market size and forecast 2019-2024 ($ billion)
•26. Psoriasis – Year-over-year growth 2019-2024 (%)
•27. MS – Market size and forecast 2019-2024 ($ billion)
•28. MS – Year-over-year growth 2019-2024 (%)
•29. Anti-inflammatory biologicals – Market size and forecast 2019-2024 ($ billion)
•30. Anti-inflammatory biologicals – Year-over-year growth 2019-2024 (%)
•31. Corticosteriods – Market size and forecast 2019-2024 ($ billion)
•32. Corticosteriods – Year-over-year growth 2019-2024 (%)
•33. NSAIDs – Market size and forecast 2019-2024 ($ billion)
•34. NSAIDs – Year-over-year growth 2019-2024 (%)
•35. Customer landscape
•36. Impact of drivers and challenges
•37. Vendor landscape
•38. Landscape disruption
•39. Industry risks
•40. Vendors covered
•41. Market positioning of vendors
•42. AbbVie Inc – Overview
•43. AbbVie Inc – Business segments
•44. AbbVie Inc – Key offerings
•45. AbbVie Inc – Key customers
•46. AbbVie Inc – Segment focus
•47. Amgen Inc – Overview
•48. Amgen Inc – Business segments
•49. Amgen Inc – Key offerings
•50. Amgen Inc – Key customers
•51. Amgen Inc – Segment focus
•52. AstraZeneca Plc – Overview
•53. AstraZeneca Plc – Business segments
•54. AstraZeneca Plc – Key offerings
•55. AstraZeneca Plc – Key customers
•56. AstraZeneca Plc – Segment focus
•57. Bayer AG – Overview
•58. Bayer AG – Business segments
•59. Bayer AG – Key offerings
•60. Bayer AG – Key customers
•61. Bayer AG – Segment focus
•62. F Hoffmann-La Roche Ltd – Overview
•63. F Hoffmann-La Roche Ltd – Business segments
•64. F Hoffmann-La Roche Ltd – Key offerings
•65. F Hoffmann-La Roche Ltd – Key customers
•66. F Hoffmann-La Roche Ltd – Segment focus
•67. GlaxoSmithKline Plc – Overview
•68. GlaxoSmithKline Plc – Business segments
•69. GlaxoSmithKline Plc – Key offerings
•70. GlaxoSmithKline Plc – Key customers
•71. GlaxoSmithKline Plc – Segment focus
•72. Johnson & Johnson – Overview
•73. Johnson & Johnson – Business segments
•74. Johnson & Johnson – Key offerings
•75. Johnson & Johnson – Key customers
•76. Johnson & Johnson – Segment focus
•77. Merck & Co Inc – Overview
•78. Merck & Co Inc – Business segments
•79. Merck & Co Inc – Key offerings
•80. Merck & Co Inc – Key customers
•81. Merck & Co Inc – Segment focus
•82. Novartis AG – Overview
•83. Novartis AG – Business segments
•84. Novartis AG – Key offerings
•85. Novartis AG – Key customers
•86. Novartis AG – Segment focus
•87. Pfizer Inc – Overview
•88. Pfizer Inc – Business segments
•89. Pfizer Inc – Key offerings
•90. Pfizer Inc – Key customers
•91. Pfizer Inc – Segment focus
•92. Currency conversion rates for US$
•93. Research Methodology
•94. Validation techniques employed for market sizing
•95. Information sources
•96. List of abbreviations



【掲載企業】

AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の抗炎症治療市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆